18-6980524-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005559.4(LAMA1):āc.6004A>Gā(p.Lys2002Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.714 in 1,564,944 control chromosomes in the GnomAD database, including 401,658 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005559.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMA1 | NM_005559.4 | c.6004A>G | p.Lys2002Glu | missense_variant | 42/63 | ENST00000389658.4 | NP_005550.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMA1 | ENST00000389658.4 | c.6004A>G | p.Lys2002Glu | missense_variant | 42/63 | 1 | NM_005559.4 | ENSP00000374309.3 | ||
LAMA1 | ENST00000579014.5 | n.7019A>G | non_coding_transcript_exon_variant | 41/62 | 2 |
Frequencies
GnomAD3 genomes AF: 0.685 AC: 104126AN: 151996Hom.: 36196 Cov.: 33
GnomAD3 exomes AF: 0.735 AC: 184537AN: 251108Hom.: 68368 AF XY: 0.733 AC XY: 99532AN XY: 135766
GnomAD4 exome AF: 0.718 AC: 1013922AN: 1412830Hom.: 365437 Cov.: 25 AF XY: 0.718 AC XY: 507326AN XY: 706436
GnomAD4 genome AF: 0.685 AC: 104198AN: 152114Hom.: 36221 Cov.: 33 AF XY: 0.690 AC XY: 51300AN XY: 74340
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 08, 2020 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 19, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at